ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 327 filers reported holding ROYALTY PHARMA PLC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $303 | -94.4% | 11,179 | -93.6% | 0.02% | -94.4% |
| Q2 2023 | $5,363 | +5.3% | 174,450 | +23.4% | 0.36% | -9.9% |
| Q1 2023 | $5,094 | -6.7% | 141,381 | +2.3% | 0.39% | -14.5% |
| Q4 2022 | $5,462 | -99.9% | 138,200 | +0.4% | 0.46% | -9.8% |
| Q3 2022 | $5,530,000 | -5.0% | 137,619 | -0.6% | 0.51% | -0.4% |
| Q2 2022 | $5,823,000 | +12.4% | 138,510 | +4.2% | 0.51% | +34.3% |
| Q1 2022 | $5,180,000 | – | 132,965 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MASSMUTUAL TRUST CO FSB/ADV | 418 | $11,742 | 0.00% |
| Versant Capital Management, Inc | 20 | $562 | 0.00% |